Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Sale | 2024-04-03 5:23 pm | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 7,523 | $6.94 | $52,210 | 95,665 (Direct) | View |
| 2023-08-01 Purchase | 2023-08-03 8:13 pm | Inozyme Pharma Inc. | INZY | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director | 833,333 | $4.8 | $3,999,998 | 1,571,741 (Indirect) | View |
| 2023-08-01 Purchase | 2023-08-03 8:01 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 833,333 | $4.8 | $3,999,998 | 1,571,741 (Indirect) | View |
| 2023-05-11 Purchase | 2023-05-15 5:06 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 447,932 | $6.3626 | $2,849,998 | 3,661,518 (Indirect) | View |
| 2023-03-29 Purchase | 2023-03-30 5:46 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 344,592 | $4.5379 | $1,563,724 | 3,213,586 (Indirect) | View |
| 2023-03-27 Purchase | 2023-03-29 7:30 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 207,840 | $4.0467 | $841,063 | 2,868,994 (Indirect) | View |
| 2022-12-15 Purchase | 2022-12-19 08:30 am | Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO | 21,500 | $1.39 | $29,885 | 105,441 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-21 6:04 pm | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,355,000 | $3.69 | $4,999,950 | 4,174,379 (Indirect) | View |
| 2022-04-19 Purchase | 2022-04-20 6:22 pm | Inozyme Pharma Inc. | INZY | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director | 1,070,000 | $3.69 | $3,948,300 | 2,661,154 (Indirect) | View |
| 2022-04-19 Purchase | 2022-04-20 4:05 pm | Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO | 27,100 | $3.69 | $99,999 | 80,626 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-20 4:05 pm | Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer | 67,750 | $3.69 | $249,998 | 258,575 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-20 4:05 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 1,070,000 | $3.69 | $3,948,300 | 2,661,154 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Exercise | 2024-04-03 5:23 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 25,000 | $0 | 95,665 (Direct) | View |
| 2024-03-28 Option Award | 2024-04-03 5:23 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 3,188 | $3.33 | 3,188 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 08:30 am | N/A 2034-03-12 | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 08:30 am | N/A 2034-03-12 | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 08:30 am | N/A 2034-03-12 | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO | 165,000 | $0 | 165,000 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 4:05 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO | 2,319 | $3.57 | 30,398 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:16 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Mathers Edward T Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Sullivan Lynne Marie Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | DIAZ REINALDO M Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Edwards Martin Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Bolte Axel Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Bhagat Sarah M Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-03 08:40 am | N/A 2033-04-30 | Inozyme Pharma Inc. | INZY | Bolte Axel Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 4:05 pm | N/A 2033-03-31 | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 900,000 | $0 | 900,000 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 08:40 am | N/A N/A | Inozyme Pharma Inc. | INZY | Bolte Axel Director | 4,806 | $2.21 | 266,696 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 08:37 am | N/A N/A | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO | 979 | $2.21 | 28,079 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-04 08:35 am | N/A 2033-04-02 | Inozyme Pharma Inc. | INZY | Winton Matthew COO | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-27 4:05 pm | N/A 2033-03-22 | Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-04 08:00 am | N/A N/A | Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer | 3,315 | $2.28 | 261,890 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-04 08:00 am | N/A N/A | Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO | 3,315 | $2.28 | 83,941 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:32 pm | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Mathers Edward T Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 07:52 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Treco Douglas A Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 07:51 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Sullivan Lynne Marie Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 07:49 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 07:48 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Edwards Martin Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 07:47 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | DIAZ REINALDO M Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 07:45 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Bhagat Sarah M Director | 9,367 | $0 | 9,367 (Direct) | View |